FTA:
In 2007, a retrospective study showed that men taking statins to lower their cholesterol also experienced a proportional decline in their PSA levels. This new study confirms that evidence and highlights the fact that cholesterol may play a role in prostate cancer development and progression. […] It remains to be seen whether or not lowering your PSA through statin medications could potentially mask the presence of prostate disease.
It would be nice if it talked about particle size! To understand why particle size matters (in the context of atherogenic dyslipidemia and heart disease), watch this video featuring @rhonda and Dr. Ronald Krauss.